|Articles|July 1, 1998

July 1998
Volume 4
Issue 7

The Cost-Effectiveness of Treatment with Lamivudine and Zidovudine Compared with Zidovudine Alone: A Comparison of Markov Model and Trial Data Estimates

Author(s)Josephine Mauskopf, PhD, Loretto Lacey, PhD, Angela Kempel, PhD

Download PDF: The Cost-Effectiveness of Treatment with Lamivudine and Zidovudine Compared with Zidovudine Alone: A Comparison of Markov Model and Trial Data Estimates

Articles in this issue

almost 28 years ago

Article

A New Method of Developing Expert Consensus Practice Guidelines

almost 28 years ago

Article

Treatment Options for Prostate Cancer: Part 1--Stage, Grade, PSA, and Changes in the 1990's

almost 28 years ago

Article

Patient Consultation in a Managed Care Setting: Guiding Pharmacy into the Future

almost 28 years ago

Article

Should Clinicians Rely on Expert Opinion or Empirical Findings?

almost 28 years ago

Article

Compliance with Anti-Hypertensive Therapy: Raising the Bar of Expectations

almost 28 years ago

Article

In Vitro and Skin Testing for Allergy: Comparable Clinical Utility and Costs

almost 28 years ago

Article

Impact of Pharmacist Consultations Provided to Patients with Diabetes on Healthcare Costs in a Health Maintenance Organization

almost 28 years ago

Article

Introducing Managed Care to the Medical School Curriculum: Effect on Student Attitudes

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Association of Travel Nursing With Quality Outcomes in Hospitalized Patients

ByJason Bartock, MD,Adam Green, MD,Raquel Nahra, MD,Amy Bordogna, MD,Amir Davoodi, MD,Jean-Sebastien Rachoin, MD

June 11th 2026

Cost of Behavioral Messaging Interventions for Cardiovascular Medication Adherence

ByDana R. Fletcher, PhD,Lisa M. Sandy, MA,Joy Waughtal, MPH,Cole Hoffman, MS,Sylvie Novins-Montague, BA,Patrick Hosokawa, MS,Pamela N. Peterson, MD, MSPH,Larry A. Allen, MD, MPH,Sheana Bull, PhD,P. Michael Ho, MD, PhD

June 10th 2026

Changes in Persistence to Basal Insulin Following the Medicare Out-of-Pocket Cost Cap

ByRazanne Oueini, PharmD,Ben Shirley, BS,Christie Teigland, PhD,Melissa Castora-Binkley, PhD, MA,Scott Bilder, PhD,Kiran Sunkari, MS,Lynn Pezzullo, RPh

June 8th 2026

US map with stethoscope | Image Credit: © Andreas Prott - stock.adobe.com

Associations Between Socioeconomic Status, Healthy Lifestyle, and Multimorbidity in the US

ByShifeng Wu, MM

June 5th 2026

Health Care Utilization in Veterans With Alzheimer Disease

ByYing Wang, PhD,Byron J. Aguilar, PhD,Mingfei Li, PhD,Peter Morin, MD, PhD,Joel Reisman, BS,Wen Hu, MS,Jong Soo Lee, PhD,Dan Berlowitz, MD, MPH,Qinqing Li, MS,Raymond Zhang, PhD,Amir Abbas Tahami Monfared, MD, PhD,Quanwu Zhang, PhD,Weiming Xia, PhD

June 4th 2026

The Cost-Effectiveness of Treatment with Lamivudine and Zidovudine Compared with Zidovudine Alone: A Comparison of Markov Model and Trial Data Estimates

Articles in this issue

Related Content

Association of Travel Nursing With Quality Outcomes in Hospitalized Patients

Cost of Behavioral Messaging Interventions for Cardiovascular Medication Adherence

Changes in Persistence to Basal Insulin Following the Medicare Out-of-Pocket Cost Cap

Associations Between Socioeconomic Status, Healthy Lifestyle, and Multimorbidity in the US

Health Care Utilization in Veterans With Alzheimer Disease

Trending on AJMC

Special Report: The Oncology Care Model, 10 Years Later

Patients on GLP-1s Increasingly Carry Diagnoses for New Indications

Long-Term Extension Data Support Durable Benefit of Rilzabrutinib in Persistent, Chronic ITP: David Kuter, MD, DPhil

Contributor: Turning Headwinds Into Momentum—How Value-Based Care Can Help Payers Manage Costs and Regain Stability

Targeting Oxidative Stress Could Fill a Gap in the Vitiligo Treatment Toolbox